ViroPharma Announces Restructuring of Operations
January 20, 2004 09:45 ET
|
ViroPharma Incorporated
EXTON, Pa., Jan. 20, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has restructured its organization to focus its resources on the advancement and...
Michael Dougherty and William Claypool, MD Join ViroPharma's Board of Directors
January 16, 2004 10:01 ET
|
ViroPharma Incorporated
EXTON, Pa., Jan. 16, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today the election of Michael Dougherty and Dr. William Claypool to its board of directors. Mr. Dougherty is...
ViroPharma Announces Advancements In Its Hemorrhagic Fever Virus Biodefense Program
December 18, 2003 07:30 ET
|
ViroPharma Incorporated
EXTON, Pa., Dec. 18, 2003 (PRIMEZONE) -- ViroPharma incorporated (Nasdaq:VPHM) today announced that it has discovered antiviral compounds active against a group of potential bioterrorism viruses...
ViroPharma and Schering-Plough Enter Into Agreement For New Intranasal Formulation of Pleconaril
November 25, 2003 12:40 ET
|
ViroPharma Incorporated
EXTON, Pa. and KENILWORTH, N.J., Nov. 25, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) and Schering-Plough Corporation (NYSE:SGP) today announced that the companies have entered into an...
ViroPharma Incorporated Reports Third Quarter Financial Results
November 06, 2003 16:58 ET
|
ViroPharma Incorporated
EXTON, Pa., Nov. 6, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the quarter ended September 30, 2003.
For the quarter ended September 30,...
ViroPharma Awarded Two SBIR Grants for Biodefense Antiviral Drug Discovery Programs
October 01, 2003 10:05 ET
|
ViroPharma Incorporated
EXTON, Pa., Oct. 1, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it was awarded two Phase 1 Small Business Innovation Research (SBIR) grants from the National...
ViroPharma Incorporated Reports Second Quarter Financial Results
August 14, 2003 10:52 ET
|
ViroPharma Incorporated
EXTON, Pa., August 14, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the quarter ended June 30, 2003.
For the quarter ended June 30, 2003, the...
ViroPharma Licenses Rights from GlaxoSmithKline for Product Candidate for Cytomegalovirus (CMV) in Immunocompromised Patients
August 11, 2003 07:30 ET
|
ViroPharma Incorporated
EXTON, Pa., Aug. 11, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the acquisition of worldwide rights (excluding Japan) from GlaxoSmithKline (GSK) to an antiviral...
ViroPharma Lead Compounds Show Potent Activity Against Smallpox Virus
July 30, 2003 07:30 ET
|
ViroPharma Incorporated
EXTON, Pa., July 30, 2003 (PRIMEZONE) -- VIROPHARMA INCORPORATED (Nasdaq:VPHM) today announced that compounds from its lead chemical series, recently shown to have potent antiviral activity against a...
ViroPharma Announces Results of Hepatitis C Phase 1b Study
July 15, 2003 16:45 ET
|
ViroPharma Incorporated
EXTON, Pa., July 15, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced results from the treatment portion of a phase 1b study with HCV-371, a hepatitis C antiviral compound...